ScImage upgrades its PACS

TriMed Staff | | Health Imaging | Screening
ScImage this week released Version 2.0 of its PICOMEnterprise PACS.

Version 2.0 enables an order-driven workflow for radiology departments while simultaneously giving other departments within the hospital a tool for acquisition, storage and distribution of both images and reports, the company said. Version 2.0 also has a new interface engine that provides a single point of entry through any third-party RIS, EMR or practice management System.

ScImage said it will demonstrate the new features and benefits of PICOMEnterprise Version 2.0 at the upcoming Radiological Society of North America meeting, Nov. 28 - Dec. 3, in Chicago. The company said it will also introduce PICOM ECG at the show. The PICOM ECG Suite is a web-enabled ECG management module that augments the cardiology offering.

TriMed Staff

Related Content

AI beats standard regression models at predicting lung cancer risk
AI reduces CT lung cancer screening workload by nearly 80%
Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.